Chair Fred Lublin, MD, FAAN, FANA Saunders Family Professor of Neurology Director, The Corinne Goldsmith Dickinson Center for Multiple Sclerosis Co-Chief Editor, Multiple Sclerosis and Related Disorders | Icahn School of Medicine at Mount Sinai New York, NY
Faculty Amy Perrin Ross, APN, MSN, CNRN, MSCN Neuroscience Program Coordinator Loyola University Medical Center Maywood, IL
1.1 contact hours
An estimated 350,000 to 500,000 people in the United States are currently diagnosed with MS, a chronic neurologic disorder with potential for substantial negative impact on quality of life. Nurses play an important role in addressing MS symptoms, managing adverse events, limiting disability, and coordinating with the collaborative care team to ensure that patients have the optimal treatment plan and adhere to it. A lack of knowledge about therapeutic risks and benefits, appropriate management of MS symptoms and comorbidities, and the necessary routine follow-up will limit patient care and result in worse outcomes.
. Target Audience
This activity is intended for RNs specializing in neurology or MS
Upon completion of this educational activity, the participant should be able to:
Describe nursing interventions for the management of common MS symptoms, such as depression, fatigue, cognitive dysfunction, and mobility impairment.
Discuss nursing interventions for risk assessment and risk management for patients receiving disease-modifying therapies for MS.
Provide appropriate care and counsel for patients and their families.
Postgraduate Institute for Medicine (PIM) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflicts of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to PIM policy. PIM is committed to providing its learners with high quality CME activities and related materials that promote improvements or quality in health care and not a specific proprietary business interest of a commercial interest.
The faculty reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:
Fred Lublin, MD, FAAN, FANA has disclosed the following:
Research Funding: Acorda Therapeutics, Inc., Biogen Idec, Novartis Pharmaceuticals Corporation, Teva Neuroscience, Genzyme, Sanofi-Aventis, Celgene, Transparency Life Sciences, NIH, NMSS
Advisory Board: Bayer HealthCare Pharmaceuticals, Biogen Idec, EMD Serono, Inc., Novartis Pharmaceuticals Corporation, Teva Neuroscience, Actelion, Sanofi-Aventis, Acorda, Questcor, Roche, Genentech, Celgene, Johnson & Johnson, Revalesio, Coronado Bioscience, Genzyme, MedImmune, Bristol-Myers Squibb, Xenoport, Receptos, Forward Pharma, to-BBB technologies
Stock Ownership: Cognition Pharmaceuticals, Inc.
Amy Perrin Ross, APN, MSN, CNRN, MSCN has disclosed the following:
Consultant: Acorda Therapeutics, Bayer HealthCare Pharmaceuticals, EMD Serono, Genzyme, Novartis, Questcor, Teva
Speakers Bureau: Acorda Therapeutics, Bayer HealthCare Pharmaceuticals, EMD Serono, Genzyme, Novartis, Questcor, Teva
The planners and managers reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:
The following PIM planners and managers, Laura Excell, ND, NP, MS, MA, LPC, NCC, Trace Hutchison, PharmD, Samantha Mattiucci, PharmD, CCMEP, and Jan Schultz, RN, MSN, CCMEP, hereby state that they or their spouse/life partner do not have any financial relationships or relationships to products or devices with any commercial interest related to the content of this activity of any amount during the past 12 months.
Gena Dolson, MCM Education Senior Medical Writer, has nothing to disclose.
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
This educational activity for 1.1 contact hours is provided by Postgraduate Institute for Medicine.
Postgraduate Institute for Medicine is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.
For questions regarding the CNE/nursing credit, contact Postgraduate Institute for Medicine at (800) 423-3576 or firstname.lastname@example.org .
Credit is awarded to participants who score 80% or better on the post-test.
The online activity will take approximately 60 minutes to complete. Commercial Support Statements
Supported by independent educational grants from Teva Pharmaceuticals and Novartis Pharmaceuticals Corporation.
There are no fees for participating in or receiving credit for this online educational activity. This activity is designed to be completed within the time designated on this page; nurses should claim only those credits that reflect the time actually spent in the activity.
Review the intended audience, learning objectives, and author disclosures.
Study the educational content online.
Once completed, continue to post-test. Online, choose the best answer to each test question. To receive a certificate, you must receive a passing score as designated at the top of the test. In addition, you must also complete the Activity Evaluation.
Computer Requirements: Minimum System Requirements: • Pentium III, 600 MHz or Equivalent Processor • 512 MB of RAM • Windows XP, Vista, or 7 • Mac OS X • 800x600 Monitor Resolution • 16-bit Color • 16 bit Sound Card with Speakers
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.